Periodontal Disease Treatment Market – Trends Forecast Till 2030

1
Periodontal Disease Treatment Market Industry
Size, Share, Demand Value Analysis
sales_at_delvens.com www.delvens.com
2
Periodontal Disease Treatment Market Industry
Size, Share, Demand Value Analysis
The Periodontal Disease Treatment market size was
estimated at USD 799.17 million in 2023 and is
projected to reach USD 1438.54 million in 2030 at
a CAGR of 8.76 during the forecast period
2023-2030. Periodontal disease treatment
typically involves a combination of professional
dental cleaning, scaling and root planning to
remove plaque and tartar, as well as addressing
any underlying issues. In severe cases, surgical
procedures might be necessary to reduce pocket
depths and promote gum tissue regeneration.
Maintaining good oral hygiene and regular dental
check-ups are also crucial for managing and
preventing periodontal disease. The growth of the
periodontal disease treatment market can be
attributed to several factors. The increasing
awareness about oral health and the consequences
of untreated periodontal disease is driving the
demand for treatment options.
Request For Free Sample Report
https//www.delvens.com/get-free-sample/periodonta
l-disease-treatment-market-trends-forecast-till-20
30
sales_at_delvens.com
www.delvens.com
3
Market Overview
On the other hand, periodontal treatments can be
expensive, especially for advanced stages, this
can limit access for individuals without adequate
insurance coverage. Moreover, dental anxiety and
fear of procedures can discourage individuals
from seeking treatment, especially when invasive
treatments are required. These factors might
hamper the growth of the market during forecast
period. The COVID-19 pandemic has had a
significant impact on the periodontal dental
treatment market. The pandemic led to a decrease
in the demand for periodontal dental treatment.
This can be attributed to the feat of contracting
COVID-19 from aerosolized particles produced
during dental procedures. Moreover, the closure
and reduced hours of operation of dental
practices led to decreased demand for periodontal
treatments. Lastly, financial constraints of
patients due to job losses and economic recession
affected the growth of the market further.
sales_at_delvens.com
www.delvens.com
4
Market Segmentation
The Periodontal Disease Treatment Market is
segmented into various segments such as type,
treatment type, drugs, route of administration,
end user, distribution channel, and region

• Based on Type
• Gingivitis
• Chronic Periodontal Disease
• Aggressive Periodontal Disease
• Others
• Based on Treatment Type
• Non-Surgical Treatment
•  
• Scaling and Root Planning
• Medication
• Surgical Treatment
•  
• Flap Surgery
• Bone Grafts
• Others

• Based on Drugs
• Systematic antibiotics
•  
• Doxycycline
• Metronidazole
• Others
• Local antibiotics
•  
• Minocycline hydrochloride
• Chlorhexidine
• Based on Route of Administration
• Oral
• Injectable

sales_at_delvens.com
www.delvens.com
5
Market Segmentation

• Based on End User
• Hospitals
• Clinic
• Dental Clinic
• Dental Academics and Research Institutes
• Others
• Based on Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others

sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• 3M
• Bausch Health Companies Inc.
• Biohorizons Implant Systems Inc.
• Colgate-Palmolive Company Limited
• Danaher Corporation
• Den-Mat Holdings LLC
• Dexcel Pharma
• Institut Straumann AG
• Izun Pharmaceuticals
• Kaken Pharmaceutical Co.,Ltd.
• Lyne Laboratories

• Medtronic PLC
• Mylan N.V.
• Noveome Biotherapeutics, Inc
• Pfizer Inc
• Sunstar Suisse S.A
• Tolmar Pharmaceuticals, Inc
• Valeant Pharmaceuticals International Inc.
• WOCKHARDT
• Xttrium Laboratories

Inquire Before Buying https//www.delvens.com/Inq
uire-before-buying/periodontal-disease-treatment-m
arket-trends-forecast-till-2030
sales_at_delvens.com
www.delvens.com
7
Recent Developments

• In April 2023, Novo Nordisk collaborated with
  Aspect Biosystems, a company involved in
  bioprinting biomaterials, for the development of
  bioprinted tissue therapeutics for obesity and
  diabetes. 
• In March 2022, Biocomposites signed an agreement
  with Zimmer Biomet to distribute the new genex
  Bone Graft Substitute. Genex Bone Graft
  Substitute is a biphasic composite of exceptional
  purity specifically formulated to balance
  osteoconductive scaffold strength and persistence
  in the body to enable the optimal remodeling of
  bone architecture.

Purchase This Report https//www.delvens.com/chec
kout/periodontal-disease-treatment-market-trends-f
orecast-till-2030
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-8638-5055 sales_at_del
vens.com WEBSITE https//delvens.com/
sales_at_delvens.com
www.delvens.com